To hear about similar clinical trials, please enter your email below
Trial Title:
Barriers and Facilitators of Parent-Child Communication in Children With Cancer Predisposition
NCT ID:
NCT05849155
Condition:
Genetic Predisposition
Conditions: Official terms:
Disease Susceptibility
Genetic Predisposition to Disease
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Summary:
Testing children, adolescents, and young adults (CAYA) for a genetic risk for cancer can
help with early prevention and detection of cancers through regular follow-ups and
medical care. After receiving genetic test results, CAYA may not accurately understand
what their results mean, and parents are often unsure about talking with their CAYA about
their genetic risk for cancer. By understanding how parents communicate with their CAYA,
the investigators can improve future genetic education to reduce cancer risk.
Primary Objectives:
- Identify qualities of parent-CAYA (child, adolescent, and young adults)
communication about CAYAs' genomic cancer risk, and their association with CAYAs'
psychosocial and prevention outcomes.
- Examine the association between sociodemographic, cancer-related, and psychosocial
factors and parent-CAYA communication regarding CAYAs' genomic risk for cancer.
- Identify barriers and facilitators of parent-CAYA communication regarding CAYAs'
genomic risk for cancer.
Detailed description:
This sequential explanatory mixed-methods, multi-informant study will include CAYAs (ages
10-24 years) with a P/LP germline variant in a known cancer predisposition gene, with
this age range selected to inform CAYA informational needs around transition to adult
care. CAYAs and parents will complete questionnaires and direct behavioral observations
of parent-CAYA communication to (1) observationally characterize the content, qualities,
and associates of parent-CAYA cancer predisposition communication and (2) examine the
association between qualities of parent-CAYA communication about CAYAs' cancer risk and
CAYAs' psychosocial and prevention outcomes. A subset of CAYAs and parents (n = 40 each)
will subsequently complete optional qualitative interviews. CAYAs and parents will be
purposively selected for these interviews based on their observed communication to
identify barriers and facilitators of parent-CAYA communication regarding genetic risk
for cancer. Rigor and reproducibility are ensured through a multi-method, multi-informant
design; a manualized approach to recruitment and data collection; standardized measures
with sound psychometric properties when available (quant); rigorous statistical tests of
proposed hypotheses (quant); data saturation and purposeful sampling for transferability
(qual); and triangulation (qual)
Criteria for eligibility:
Study pop:
Children, adolescents, and young adults (CAYAs) aged 10-24 years with a pathogenic/likely
pathogenic variant in a known cancer predisposition gene and their parents
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Patient aged 10 to 24 years (inclusive)
- Patient underwent germline genetic testing with a Pathogenic/Likely Pathogenic
(P/LP) variant in a known cancer predisposition gene that increases risk for
developing cancer
- P/LP result disclosed to the patient
- Patient has a primary caregiver willing to participate
- Patient and participating caregiver able to speak and read English
Exclusion Criteria:
- Patient is only a carrier of a recessive variant that does not alone increase risk
for cancer
- Inability or unwillingness of patient or participating caregiver or to give informed
consent/assent
- Participating caregiver is under the age of 18 years
- Patient or participating caregiver has evidence of significant cognitive deficits
(per medical record) that would interfere with the ability to comprehend study
questions
- Patient's medical status or condition precludes completion of study (as determined
by medical team, patient, or parent)
Gender:
All
Minimum age:
10 Years
Maximum age:
24 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
St. Jude Children's Research Hospital
Address:
City:
Memphis
Zip:
38105
Country:
United States
Status:
Recruiting
Contact:
Phone:
866-278-5833
Email:
referralinfo@stjude.org
Start date:
December 12, 2023
Completion date:
October 2028
Lead sponsor:
Agency:
St. Jude Children's Research Hospital
Agency class:
Other
Source:
St. Jude Children's Research Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05849155
http://www.stjude.org
http://www.stjude.org/protocols